Cyrano Therateutics
Delray Beach, US · 4 known investors
Find your way into Cyrano Therateutics
Sign up to see every warm intro you have to Cyrano Therateutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyrano Therateutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.
Founders & leadership
Investors · 4
Remiges Ventures, Inc.✓ confirmed by Cyrano TherateuticsSeattle
How we know: Remiges Ventures, Inc.'s portfolio page · the company's own site · Not right? Tell us
DeepWork Capital✓ confirmed by Cyrano TherateuticsOrlando
How we know: the company's own site · Not right? Tell us
Related companies · 1
Companies working in the same space as Cyrano Therateutics.
Frequently asked questions
- What does Cyrano Therateutics do?
- Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.
- Who founded Cyrano Therateutics?
- Cyrano Therateutics was founded by Rick Geoffrion.
- Who are Cyrano Therateutics's investors?
- Cyrano Therateutics's investors include Remiges Ventures, Inc., DeepWork Capital, Lumira Ventures, Florida Opportunity Fund.
- Where is Cyrano Therateutics headquartered?
- Cyrano Therateutics is headquartered in Delray Beach, US.

